论文部分内容阅读
我国现有6700多个制药企业,能生产原料药、中间体、制剂、药用敷料及药用包装和制药机械等,形成了较为完整的制药工业生产体系。其中包括生产化学原料药1400种、制剂药4000多种;中成药30余万吨,品种规格达8000多种。化学原料药产量1999年达到43万吨,其中二十四大类原料药26万吨,成为世界原料药第二大生产国。其中青霉素及β-内酰胺类药物和维生素等已成为最大生产国和出口国。 “九五”计划的五年,我国医药经济继续保持连续高速增长的势头,医药工业总产值、工业资产总量、医药商业销售额在“九五”前4年分别达到年均
China’s existing more than 6,700 pharmaceutical companies, capable of producing bulk drugs, intermediates, preparations, pharmaceutical dressings and pharmaceutical packaging and pharmaceutical machinery, formed a relatively complete pharmaceutical industrial production system. Including the production of 1,400 kinds of chemical raw materials, pharmaceutical preparations more than 4,000 kinds; proprietary Chinese medicines more than 30 million tons, more than 8,000 species specifications. In 1999, the output of chemical raw materials reached 430,000 tons, of which 260,000 tons were raw materials for 24 major categories, making it the second largest producer of raw material medicine in the world. Among them, penicillin and β-lactam drugs and vitamins have become the largest producer and exporter. In the five years of the Ninth Five-Year Plan, China’s pharmaceutical economy continued to maintain a momentum of continuous and rapid growth. The total output value of pharmaceutical industry, the total industrial assets and the commercial sales of medicine reached the annual average of